Dr. Christopher James McCabe, MD

Dr. McCabe practices at Sharp Chula Vista Medical Center in Chula Vista, California, part of Sharp HealthCare.

Dr. McCabe's NPI, 1316470933, was assigned on April 10, 2017. Dr. McCabe holds Arizona license 59945.

Dr. McCabe's primary practice is Sharp Chula Vista Medical Center, at 751 Medical Center Court, Chula Vista, CA 91911 in San Diego County. The practice phone is (619) 502-5800.

Dr. McCabe's primary practice is Sharp Chula Vista Medical Center in Chula Vista, California, part of Sharp HealthCare. Dr. McCabe is also affiliated with Valleywise Health Medical Center. The medical group on file is Vituity. Dmand AI also links Dr. McCabe to 1 more hospital and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McCabe practices, 3 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. McCabe's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dmand AI has Dr. McCabe's licenses on file in 2 states: Arizona and California.

CMS data shows 1,741 Medicare services from Dr. McCabe across 6 procedure codes in 2024, for 1,132 Medicare patients. Medicare paid $157,322 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 1,132 Medicare patients who saw Dr. McCabe in 2024. The largest group is 75 to 84, with 497 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. McCabe's median patient age at 56, with 59% women.

In 2024, Dr. McCabe wrote 123 Medicare Part D claims for 98 patients. 98% of them were for generic drugs. CMS names the drug for 35 of them, across 2 drugs with 11 or more claims each, at $297 in total drug cost. In 2023, CMS named 37 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. McCabe for performance year 2024, reported as part of a group. Dr. McCabe accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Dr. McCabe from 1 drug or device company from 2022 to 2023. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $36.